• About SOSEI
  • Pipeline
  • Business Development
  • News
  • Investor Relations
  • Company Overview
  • Vision
  • Board&Management
  • Corporate Governance
  • History

History

date notes
22 Jun 1990  
June S. Tamura and T. Nakamura incorporated Sosei
1991-1999  
  Established globally recognised technology transfer business
1999  
Mar Started the Drug Reprofiling Platform®(DRP®) project.
2001  
April In-licensed Norlevo® from Laboratoire HRA Pharma.
2002  
September Established Sosei London office.
2004  
July Listed on the MOTHERS index of Tokyo Stock Exchange (code:4565).
2005  
August Acquisition of Arakis Ltd.(now Sosei R&D Ltd.)
2006  
October Reorganisation under a holding company structure
TOP